Zobrazeno 1 - 10
of 2 913
pro vyhledávání: '"Mozzillo, N."'
Autor:
Rossi, C.R. *, Mozzillo, N., Maurichi, A., Pasquali, S., Quaglino, P., Borgognoni, L., Solari, N., Piazzalunga, D., Mascheroni, L., Giudice, G., Mocellin, S., Patuzzo, R., Caracò, C., Ribero, S., Marone, U., Santinami, M.
Publikováno v:
In Annals of Oncology January 2014 25(1):240-246
Autor:
Di Monta, G., Caracò, C., Benedetto, L., La Padula, S., Marone, U., Tornesello, M.L., Buonaguro, F.M., Simeone, E., Ascierto, P.A., Mozzillo, N.
Publikováno v:
In European Journal of Surgical Oncology January 2014 40(1):61-66
Autor:
Caracò, C., Mozzillo, N., Di Monta, G., Botti, G., Anniciello, A.M., Marone, U., Di Cecilia, M.L., Staibano, S., De Rosa, G.
Publikováno v:
In European Journal of Surgical Oncology October 2012 38(10):932-935
Publikováno v:
In European Journal of Surgical Oncology 2006 32(9):970-973
Autor:
Han D; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA. handal@ohsu.edu., Han G; Department of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, College Station, TX, USA., Duque MT; Department of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, College Station, TX, USA., Morrison S; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA., Leong SP; California Pacific Medical Center and Research Institute, San Francisco, CA, USA., Kashani-Sabet M; California Pacific Medical Center and Research Institute, San Francisco, CA, USA., Vetto J; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA., White R; Levine Cancer Institute, Carolinas Medical Center, Atrium Health, Charlotte, NC, USA., Schneebaum S; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel., Pockaj B; Mayo Clinic, Phoenix, AZ, USA., Mozzillo N; Instituto Tumori Napoli Fondazione G. Pascale, Naples, Italy., Sondak VK; Moffitt Cancer Center, Tampa, FL, USA., Zager JS; Moffitt Cancer Center, Tampa, FL, USA.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2021 Feb; Vol. 28 (2), pp. 1007-1016. Date of Electronic Publication: 2020 Jun 10.
Autor:
Morrison S; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA., Han G; Department of Epidemiology and Biostatistics, Texas A&M University, College Station, TX, USA., Elenwa F; Department of Epidemiology and Biostatistics, Texas A&M University, College Station, TX, USA., Vetto JT; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA. vettoj@ohsu.edu., Fowler G; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA., Leong SP; California Pacific Medical Center and Research Institute, San Francisco, CA, USA., Kashani-Sabet M; California Pacific Medical Center and Research Institute, San Francisco, CA, USA., Pockaj B; Mayo Clinic, Phoenix, AZ, USA., Kosiorek HE; Mayo Clinic, Phoenix, AZ, USA., Zager JS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Messina JL; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA., Mozzillo N; Istituto Tumori Napoli Fondazione G. Pascale, Naples, Italy., Schneebaum S; Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel., Han D; Division of Surgical Oncology, Oregon Health and Science University, Portland, OR, USA.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2022 May; Vol. 29 (5), pp. 2854-2866. Date of Electronic Publication: 2022 Jan 21.
Autor:
Mozzillo, N., Caracò, C. ∗, Chiofalo, M.G., Celentano, E., Lastoria, S., Botti, G., Ascierto, P.A.
Publikováno v:
In European Journal of Surgical Oncology 2004 30(4):440-443
Publikováno v:
European Journal of Epidemiology, 1988 Sep 01. 4(3), 357-359.
Externí odkaz:
https://www.jstor.org/stable/3520931
Autor:
Morrison SL; Division of Surgical Oncology, Oregon Health and Science University, Portland, Oregon., Han G; Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas., Elenwa F; Department of Epidemiology and Biostatistics, Texas A&M University, College Station, Texas., Vetto JT; Division of Surgical Oncology, Oregon Health and Science University, Portland, Oregon., Fowler G; Division of Surgical Oncology, Oregon Health and Science University, Portland, Oregon., Leong SP; California Pacific Medical Center and Research Institute, San Francisco, California., Kashani-Sabet M; California Pacific Medical Center and Research Institute, San Francisco, California., Pockaj BA; Mayo Clinic, Phoenix, Arizona., Kosiorek HE; Mayo Clinic, Phoenix, Arizona., Zager JS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, Florida., Sondak VK; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, Florida., Messina JL; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida., Mozzillo N; Istituto Tumori Napoli Fondazione G. Pascale, Naples, Italy., Schneebaum S; Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel., Han D; Division of Surgical Oncology, Oregon Health and Science University, Portland, Oregon.
Publikováno v:
Cancer [Cancer] 2022 Apr 01; Vol. 128 (7), pp. 1418-1428. Date of Electronic Publication: 2022 Feb 01.
Autor:
Cordaro FG, De Presbiteris AL, Camerlingo R, Miceli R, Fratangelo F, Mozzillo N, Pirozzi G, Cavalcanti E, Manca A, Palmieri G, Cossu A, Patriarca EJ, Ciliberto E, Ascierto PA, Caputo E
Publikováno v:
Oncology Reports (Online) (2016).
info:cnr-pdr/source/autori:Cordaro FG, De Presbiteris AL, Camerlingo R, Miceli R, Fratangelo F, Mozzillo N, Pirozzi G, Cavalcanti E, Manca A, Palmieri G, Cossu A, Patriarca EJ, Ciliberto E, Ascierto PA, Caputo E/titolo:Phenotype characterization of human melanoma cells resistant to Dabrafenib/doi:/rivista:Oncology Reports (Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Cordaro FG, De Presbiteris AL, Camerlingo R, Miceli R, Fratangelo F, Mozzillo N, Pirozzi G, Cavalcanti E, Manca A, Palmieri G, Cossu A, Patriarca EJ, Ciliberto E, Ascierto PA, Caputo E/titolo:Phenotype characterization of human melanoma cells resistant to Dabrafenib/doi:/rivista:Oncology Reports (Online)/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
Combined B-RAF and MEK inhibition elicits rapid anti-tumor responses in the most patients with B-RAF (V600E) mutant metastatic melanoma. However, combined treatment is not a sufficient strategy to overcome drug resistance development. We selected in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::0952ca4336f6721cea616e55bdfee4ce
https://publications.cnr.it/doc/361230
https://publications.cnr.it/doc/361230